Health Catalyst (HCAT) Q3 Earnings: What To Expect

Core Insights - Health Catalyst is set to report its earnings results after market hours, with analysts expecting a revenue decline of 1.8% year on year to $75.01 million, contrasting with a 3.5% increase in the same quarter last year [2] - The company reported revenues of $80.72 million last quarter, marking a 6.3% year-on-year increase, but missed full-year revenue guidance expectations significantly [1][3] - Health Catalyst has generally met or exceeded Wall Street's revenue estimates, missing them only once in the past two years, with an average outperformance of 0.6% [3] Revenue Expectations - Analysts anticipate a revenue decline for the upcoming quarter, with adjusted earnings expected at $0.07 per share [2] - The company’s full-year revenue guidance has significantly missed analysts' expectations, indicating potential challenges ahead [1] Peer Comparison - In the data analytics segment, peers like Strategy and Palantir Technologies have reported strong revenue growth, with Strategy achieving 10.9% year-on-year growth and Palantir reporting a 62.8% increase [4] - The performance of these peers may provide insights into market expectations for Health Catalyst's upcoming results [4] Market Sentiment - Investors in the data analytics sector have shown steady hands, with share prices remaining flat over the past month; however, Health Catalyst's stock has increased by 6.8% during this period [5] - The average analyst price target for Health Catalyst is $4.33, significantly higher than its current share price of $2.83, indicating potential upside [5]